Showing 1 - 10 of 74
Persistent link: https://www.econbiz.de/10003843839
Persistent link: https://www.econbiz.de/10003914626
In this paper, we describe the emergence and evolution of pharmaceutical research at the German company E. Merck during the late 19th and early 20th century. Revolutionary changes in the scientific knowledge base, especially the rise of bacteriological research, and the market entry of dyestuff...
Persistent link: https://www.econbiz.de/10003730528
This paper offers a detailed case study of the emergence, organization, and development of research and development at E. Merck. During the 1890s, revolutionary changes in the scientific knowledge base, especially the rise of bacteriological research and the entry of dyestuff producers into the...
Persistent link: https://www.econbiz.de/10014200193
In this paper, we describe the emergence and evolution of pharmaceutical research at the German company E. Merck during the late 19th and early 20th century. Revolutionary changes in the scientific knowledge base, especially the rise of bacteriological research, and the market entry of dyestuff...
Persistent link: https://www.econbiz.de/10014219809
Persistent link: https://www.econbiz.de/10002113725
Persistent link: https://www.econbiz.de/10009577713
23 Stock Exchanges were in operation in Germany in 1913. We provide new data about the number of listed firms, their market value, and the number of IPOs between 1897 and 1913 for all exchanges. We assess reasons why a firm opts to be listed at a certain exchange. Large firms tend to be listed...
Persistent link: https://www.econbiz.de/10010370365
Persistent link: https://www.econbiz.de/10003475541
Persistent link: https://www.econbiz.de/10003082547